Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
Diabetes Mellitus, Type 2
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type 2 focused on measuring Continuous Glucose Monitoring, Health Disparity
Eligibility Criteria
Inclusion Criteria: Chinese Americans 40 years and older who are 1st generation immigrants, currently residing in the US, and clinically diagnosed with T2D. CGM-naïve HbA1c >7.5% within 3 months of study commencement. Participants should also possess a smartphone, as this is needed in order to facilitate the collection of CGM data by the study team as well as homogenize CGM usage education. Exclusion Criteria: Known diagnosis of dysfunction/dementia or learning disabilities Not fluent in either English or Chinese Currently undergoing or planning to undergo diathermy or high-frequency heat treatments in whom CGM use may be contraindicated Inability to travel due to frailty or health reasons Lack of internet access Critically ill populations, including those on dialysis Vulnerable populations (prisoners and women who are pregnant or planning to be pregnant during the time of study)
Sites / Locations
- Joslin Diabetes CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Participants on CGM
Participants on Finger-stick only
Participants in this group will be offered a CGM device for glucose monitoring, with training and educational materials provided in either English or Chinese, according to the participant's preference.
Participants in this group continue standard fingerstick self-monitoring of blood glucose (FSGM) as per standard care protocol. They will also receive educational materials provided in either English or Chinese, according to the participant's preference.